EPO Grants EP3799568A1 to Oregon Health & Science University for Anti-AAV2 Capsid Antibody Epitopes
Summary
The European Patent Office granted Patent EP3799568A1 to Oregon Health & Science University on April 15, 2026, covering human anti-AAV2 capsid polyclonal antibody epitopes. The patent names three inventors: ADACHI Kei, CHANG Xiao Lan, and NAKAI Hiroyuki. The designated contracting states cover all EU member states plus associated countries including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR. This represents a confirmed patent grant for gene therapy vector research, with the invention classified under IPC codes A61K, C07K, and C12N.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 46 changes logged to date.
What changed
The European Patent Office granted Patent EP3799568A1, a first-publication (A1) European patent application covering human anti-AAV2 capsid polyclonal antibody epitopes. This represents a confirmed grant of exclusivity for the applicant Oregon Health & Science University across all designated EU contracting states.
For manufacturers and researchers in the gene therapy or AAV vector space, this patent establishes intellectual property protection around specific capsid antibody epitopes. Competitors developing similar immunogenic mapping or antibody screening technologies against AAV2 may need to evaluate freedom-to-operate implications. The patent's broad designated state coverage means protection extends across all listed European jurisdictions simultaneously.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HUMAN ANTI-AAV2 CAPSID POLYCLONAL ANTIBODY EPITOPES
Publication EP3799568A1 Kind: A1 Apr 15, 2026
Applicants
Oregon Health & Science University
Inventors
ADACHI, Kei, CHANG, Xiao Lan, NAKAI, Hiroyuki
IPC Classifications
A61K 35/76 20150101AFI20220602BHEP A61K 35/761 20150101ALI20220602BHEP A61K 39/235 20060101ALI20220602BHEP C07K 14/005 20060101ALI20220602BHEP C12N 15/09 20060101ALI20220602BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.